Status:
COMPLETED
Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Overactive Bladder Syndrome
Eligibility:
FEMALE
20-99 years
Brief Summary
The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.
Eligibility Criteria
Inclusion
- patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics \& Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01819168
Start Date
March 1 2013
End Date
April 1 2016
Last Update
September 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050